Streptococcus Patents (Class 424/93.44)
-
Publication number: 20140271585Abstract: Use of a probiotic for the treatment of chronic idiopathic emesis in canines and felines.Type: ApplicationFiled: March 12, 2014Publication date: September 18, 2014Applicant: The lams CompanyInventor: Jean Soon Park
-
Publication number: 20140248246Abstract: The present invention relates to edible webs comprising microorganisms, such as probiotics. In particular, the present invention relates to an edible web having microorganisms, such as bacteria, probiotic bacteria, bacteriophages or viruses printed thereon, e.g. by the use of inkjet printing. In addition the invention relates to methods of producing such edible webs, to various products comprising the edible webs as well as to use of the edible webs comprising microorganisms.Type: ApplicationFiled: October 5, 2012Publication date: September 4, 2014Inventor: Martinas Kuslys
-
Publication number: 20140234279Abstract: A feed additive composition comprising a direct fed microbial in combination with a protease, a xylanase, an amylase and a phytase, and a method for improving the performance of a subject or for improving digestibility of a raw material in a feed (e.g. nutrient digestibility, such as amino acid digestibility), or for improving nitrogen retention, or for avoiding the negative effects of necrotic enteritis or for improving feed conversion ratio (FCR) or for improving weight gain in a subject or for improving feed efficiency in a subject or for modulating (e.g. improving) the immune response of the subject or for promoting the growth of beneficial bacteria in the gastrointestinal tract of a subject, which method comprising administering to a subject a direct fed microbial in combination with a protease, a xylanase, an amylase and a phytase.Type: ApplicationFiled: January 19, 2012Publication date: August 21, 2014Applicant: DUPONT NUTRITION BIOSCIENCES APSInventor: Luis Fernando Romero Millan
-
Publication number: 20140193464Abstract: A dry, stable and viable probiotic composition comprising, a probiotic microorganism and a dried plant powder, with the proviso that said composition is not a blended mixture of at least one biologically pure Pediococcus acidilactici probiotic culture and dried tomato powder at a weight ratio of 1:4 encapsulated in an effective amount in a gelatin capsule.Type: ApplicationFiled: January 8, 2013Publication date: July 10, 2014Applicant: IMAGILIN TECHNOLOGY, LLCInventor: Jhy-Jhu Lin
-
Publication number: 20140193367Abstract: The invention relates to a probiotic composition for reducing uremic toxins and the manufacturing method thereof. The probiotic composition comprises at least one selected from the group consisting of: Lactobacillus plantarum BCRC 12251, Lactobacillus paracasei BCRC 12188, Streptococcus thermophilus BCRC 13869 and pharmaceutically acceptable vehicles, excipients, diluents, adjuvants, etc. The invention further relates to a probiotic composition consisted of Lactobacillus plantarum BCRC 12251, Lactobacillus paracasei BCRC 12188, Streptococcus thermophilus BCRC 13869 and pharmaceutically acceptable vehicles, excipients, diluents, adjuvants, etc. In addition, the invention relates to a novel use of the probiotic composition for reducing uremic toxins, wherein the uremic toxins are protein-bound uremic toxins.Type: ApplicationFiled: March 15, 2013Publication date: July 10, 2014Applicants: NATIONAL TAIWAN UNIVERSITY, CONMED PHARMACEUTICAL & BIO-MEDICAL CORPORATIONInventors: Chen-Yu Fang, Bao-Ji Chen, Ming-Ju Chen, Je-Ruei Liu
-
Patent number: 8771673Abstract: A method of combating rheumatoid arthritis, comprising administering to a human subject in need thereof, an effective oral dose of a probiotic composition in an oral dose form including, as the only bacterial species therein, the bacterial species of Bacillus subtilis, Bacillus coagulans, and Enterococcus faecium. The initial occurrence, and progress of remission of the rheumatoid arthritis condition incident to such probiotic therapy, may be established and monitored by assay of rheumatoid factor and/or anti-CCP antibodies present in a blood sample of the human subject.Type: GrantFiled: June 5, 2012Date of Patent: July 8, 2014Assignee: Cobb & AssociatesInventors: Mark L. Cobb, Alyson J. Cobb
-
Patent number: 8758013Abstract: Prosthetic apparatuses with probiotic microorganisms to control colonization of pathogenic bacteria are disclosed. The prosthetic apparatus may include a first portion having a first mating surface, a second portion having a second mating surface that conforms to the first mating surface, and at least one strain of probiotic microorganisms retained between the first and second mating surfaces prior to implantation of the prosthetic apparatus.Type: GrantFiled: February 24, 2012Date of Patent: June 24, 2014Assignee: Zimmer Dental, Inc.Inventor: John Zacharia
-
Patent number: 8753624Abstract: An isolated Lactobacillus paracasei strain GMNL-133 is disclosed, which was deposited in the China Center for Type Culture Collection (CCTCC) under the accession number of CCTCC M 2011331 is disclosed. The isolated Lactobacillus paracasei strain GMNL-133 is used for preparing a composition for use in the treatment of atopic dermatitis or other allergic diseases in an effective amount. And a composition for use in the treatment of atopic dermatitis or other allergic diseases comprises an effective amount of the Lactobacillus paracasei strain GMNL-133 is also disclosed.Type: GrantFiled: October 14, 2011Date of Patent: June 17, 2014Assignee: GenMont Biotech IncorporationInventors: Ying-Chen Lu, Feng-Ching Hsieh
-
Publication number: 20140161781Abstract: The invention relates to a zinc-enriched biomass comprising living or subsequently killed micro-organisms, selected from the group consisting of Streptococcus thermophilus and Bifidobacterium animalis subsp. lactis and combinations thereof, a method for the manufacture of said zinc-enriched biomass, as well as food preparations, nutraceutic products, functional foods, cosmetic and cosmeceutic products, and food supplements, comprising the said biomass. Furthermore, new micro-organism strains are described which are able to concentrate zinc within the cell in very high amounts and therefore are particularly suitable for use in the method of the invention.Type: ApplicationFiled: November 4, 2013Publication date: June 12, 2014Inventors: Alberto BENEDETTI, Francesco GIRARDO
-
Publication number: 20140161780Abstract: A protein-rich nutritional food product composed of a probiotic and an edible isolated protein. The probiotic component may comprise Lactobacillus, Bacillus, Streptococcus Bifidobacteria, Saccharomyces or Leuconostoc. The isolated protein may comprise whey proteins, whey growth factor extract, glutamine peptide, egg albumen, soy proteins, or caseinates. This nutritional composition can be in the form of a food product, dietary supplement, or medical food which, upon ingestion, will promote a healthy intestinal microenvironment, provide a source of protein, and assist in the elimination of nitrogenous waste products that can build up in concentration in the circulating blood. Increased concentrations of the wastes are known to exert a negative impact on an individual's physiology and contribute to a decreased sense of well-being and general malaise. Methods for removing nitrogenous waste products from the blood and ameliorating renal failure using the nutritional product of the invention are also provided.Type: ApplicationFiled: September 12, 2011Publication date: June 12, 2014Applicant: Kibow Biotech ,Inc.Inventor: Natarajan Ranganathan
-
Publication number: 20140147426Abstract: The present invention discloses different specific bacterial strains isolated from individuals without caries which are characterised in that they present inhibitory activity against cariogenic organisms. The invention also discloses a process for isolating said strains, as well as bioactive peptides, such as anti-microbial peptides of human and bacterial origin, which also show anti-cariogenic activity. Moreover, the present invention also discloses pharmaceutical and/or probiotic/prebiotic compositions, functional foods, mouthwashes, toothpaste, chewing gum, etc., that comprise at least one of the strains and/or at least one of the bioactive peptides described in the invention, or a combination thereof, which are useful in the treatment and/or prevention of infectious diseases of the buccal cavity, preferably caries.Type: ApplicationFiled: August 31, 2011Publication date: May 29, 2014Applicant: CENTRO SUPERIOR DE INVESTIGACION EN SALUD PUBLICA (CSISP)Inventor: Alejandro Mira Obrador
-
Patent number: 8734784Abstract: The invention relates to a composition comprising a combination of an elder extract (Sambucus nigra) and a strain of L. paracasei, L. casei, L. bulgaricus or S. thermophilus, intended for stimulating immunity and/or promoting an anti-infectious and/or anti-inflammatory response.Type: GrantFiled: October 16, 2009Date of Patent: May 27, 2014Assignees: Pierre Fabre Medicament, Compagnie Gervais DanoneInventors: Anne Mandeau, Christine Libon, Marie-Françoise Aries, Gianfranco Grompone, Violeta Niborski
-
Publication number: 20140140970Abstract: An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1, H-2, Lewisb and Lewisy antigens and derivatives thereof (e.g., a sialylated form of Lewis a, Lewis x, Lewis b, Lewis y; H-1, H-2, Lewis a, Lewis x, Lewis b or Lewis y).Type: ApplicationFiled: October 2, 2013Publication date: May 22, 2014Applicants: Children's Hospital Medical Center, Instituto Nacional de Ciencias Medicas Y Nutricion, The General Hospital CorporationInventors: Ardythe L. Morrow, David S. Newburg, Guillermo M. Ruiz-Palacios
-
Publication number: 20140140971Abstract: The invention relates to a composition which, depending on the user, may be taken as a nutritional, dietetic or strictly therapeutic preparation, comprising as its active substance alkaline sphingomyelinase which is capable of preventing or treating various pathological conditions including cancerous processes, inflammatory processes of the intestine, hypercholesterolaemia and infections with Helicobacter pylori.Type: ApplicationFiled: January 27, 2014Publication date: May 22, 2014Applicant: VSL PHARMACEUTICALS INC.Inventor: Claudio DE SIMONE
-
Patent number: 8728461Abstract: A novel lactic acid bacterium strain is found, which has a high IgA production-inducing ability and a high immunostimulating activity, and belongs to the genus Enterococcus. Thus, provided is an excellent lactic acid bacterium preparation for foods or feeds, which has a high enteric colonization rate. Specifically disclosed are: a novel lactic acid bacterium Enterococcus faecium NHRD IHARA (FERM BP-11090) which has a high IgA production-inducing ability and a high immunostimulating activity; and a lactic acid bacterium preparation for enhancing the production of immunoglobulin A, which comprises a culture of the bacterium strain, an extract of the bacterium strain, or a product of any treatment of cells of the bacterium strain.Type: GrantFiled: March 30, 2009Date of Patent: May 20, 2014Assignee: Nippon Meat Packers, Inc.Inventors: Yasuhiro Ihara, Hiroshi Murakami, Yoichi Takahagi
-
Patent number: 8728490Abstract: Described are Streptococcus suis infections in pigs, vaccines directed against those infections and tests for diagnosing S. suis infections. Provided is an isolated or recombinant nucleic acid encoding a capsular gene cluster of S. suis or a gene or gene fragment derived therefrom. Further provided is a nucleic acid probe or primer allowing species or serotype-specific detection of S. suis. Also provided is a Streptococcus suis antigen and vaccine derived therefrom.Type: GrantFiled: June 16, 2010Date of Patent: May 20, 2014Assignee: Stichting Dienst Landbouwkundig OnderzoekInventor: Hilda Elizabeth Smith
-
Publication number: 20140127176Abstract: The present invention relates to compositions and methods for preventing and treating periodontitis and other conditions. In particular, the present invention relates to oral bacteria for use in treating and preventing diseases and conditions.Type: ApplicationFiled: March 2, 2012Publication date: May 8, 2014Applicants: TUFTS MEDICAL CENTER, TUFTS UNIVERSITYInventors: Linden Hu, Brian A. Klein, Elizabeth Tenorio
-
Publication number: 20140065210Abstract: The present invention relates to a personal care product comprising a protein matrix wherein said protein matrix comprises at least one protein, at least one probiotic and a carrier fluid. The present invention also relates to the personal care product being a feminine care product particularly aimed at female urogenital health to treat or prevent vaginal infections. Oral and sinus infections, however, may also be benefited by the composition.Type: ApplicationFiled: August 29, 2012Publication date: March 6, 2014Inventors: David W. Koenig, Neil T. Scholl, Vasily A. Topolkaraev, Amy L. Vanden Heuvel
-
Publication number: 20140056863Abstract: Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional compositions may provide for retention of lean body mass, which helps to avoid loss of independence and functionality, as well as to improve quality of life especially in the elderly at risk of sarcopenia and frailty. The nutritional compositions include ?-hydroxyisocaproic acid eicosapentaenoic acid. It may include other functional ingredients such as, but not limited to whey protein including whey protein micelles, prebiotic fibers, citrulline, ?-ketoglutarate, L-carnitine, nucleotides, and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 18, 2012Publication date: February 27, 2014Applicant: Nestec S.A.Inventors: Norman Alan Greenberg, Denis Breuille, Zamzam kabiry (Fariba) Roughead, Doug Bolster, Jennifer Mager
-
Publication number: 20140056862Abstract: Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional compositions may provide for retention of lean body mass, which helps to avoid loss of independence and functionality, as well as to improve quality of life especially in the elderly at risk of sarcopenia and frailty. The nutritional compositions include ?-hydroxyisocaproic acid and ?-ketoglutarate. The composition may include other functional ingredients such as, but not limited to whey protein including whey protein micelles, prebiotic fibers, citrulline, eicosapentaenoic acid, L-carnitine, nucleotides, and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 18, 2012Publication date: February 27, 2014Applicant: Nestec S.A.Inventors: Norman Alan Greenberg, Denis Breuille, Zamzam Kabiry (Fariba) Roughead, Doug Bolster, Jennifer Mager
-
Publication number: 20140037688Abstract: The subject invention provides materials and methods that effectively support innate immunity and/or disperse pathogenic biofilms using readily available, nontoxic, natural substances, while supporting restoration of normal microbiotic homeostasis. In one embodiment, the subject invention provides anti-biofilm compositions comprising one or more probiotic organisms, anti-microbial honey, and other ingredients such as prebiotic compounds, other hive products, green tea derivatives, other plant derivatives, and vitamin D3.Type: ApplicationFiled: November 4, 2011Publication date: February 6, 2014Applicant: QUORUM INNOVATIONS, LLCInventors: Eva A. Berkes, Nicholas T. Monsul
-
Publication number: 20140037602Abstract: Nutritional compositions for improving, treating and/or preventing various medical conditions and methods of using same are provided. The medical conditions may include allergies, autoimmune diseases, among others. The nutritional compositions include branched chain fatty acids and may include other functional ingredients such as, but not limited to probiotics, nucleotides and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 12, 2012Publication date: February 6, 2014Applicant: NESTEC S.A.Inventors: Doug Bolster, Norman Alan Greenberg, Jennifer Mager, Zamzam Kabiry (Fariba) Roughead
-
Publication number: 20140037604Abstract: Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional compositions may provide for retention of lean body mass, which helps to avoid loss of independence and functionality, as well as to improve quality of life especially in the elderly at risk of sarcopenia and frailty. The nutritional compositions include ?-hydroxyisocaproic acid and may include other functional ingredients such as, but not limited to whey protein including whey protein micelles, prebiotic fibers, L-carnitine, nucleotides, and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 18, 2012Publication date: February 6, 2014Applicant: NESTEC S.A.Inventors: Norman Alan Greenberg, Denis Breuille, Zamzam Kabiry (Fariba) Roughead, Doug Bolster, Jennifer Mager
-
Publication number: 20140037601Abstract: Nutritional compositions for improving, treating and/or preventing various medical conditions and methods of using same are provided. The medical conditions may include wounds, mucositis among others. The nutritional compositions include branched chain fatty acids and may include other functional ingredients such as, but not limited to probiotics, nucleotides and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 12, 2012Publication date: February 6, 2014Applicant: NESTEC S.A.Inventor: Norman Alan Greenberg
-
Publication number: 20140037553Abstract: To provide a bacterium-based microrobot which can be specifically targeted to cancer in vivo, the present invention provides a drug delivery system for cancer tissue, comprising a bacterium, and a microbead encapsulated with at least one drug, wherein biotin is bound to a surface of the bacterium and a surface of the microbead is coated with streptavidin.Type: ApplicationFiled: July 29, 2013Publication date: February 6, 2014Applicant: Industry Foundation of Chonnam National UniversityInventors: Suk Ho Park, Jong Oh Park, Sung Jun Park, Seong Young Ko, Jung Joon Min, Seung Hwan Park
-
Publication number: 20140030194Abstract: The disclosure provides oral compositions and methods of using such compositions in treating subjects infected with one or more hepatic disorders. The compositions include lysates or cell wall extracts of one or more gram positive bacteria, exhibit particular activity against hepatitis C virus (HCV), and may be useful in treating those infected with HCV as well as other hepatic diseases or disorders. Also described are methods of treating a hepatic disease or disorder by administering a therapeutically effective amount of at least one therapeutically active agent capable of upregulating or downregulating the Complement system pathway, wherein the therapeutically active agent enhances the formation of one or more convertase enzymes.Type: ApplicationFiled: January 16, 2013Publication date: January 30, 2014Applicant: Labyrinth Bio, Inc.Inventor: Elizabeth McKenna
-
Publication number: 20140030241Abstract: Nutritional compositions having dietary nucleotides, ?-3 fatty acids and citrulline are provided. The nutritional compositions may be formulated to improve T cell function, increase arginine availability in vivo, regulate myeloid-derived suppressor cells (“MDSC”), and decrease the risk and/or severity of infection after surgery or trauma. Methods of making, using and administering such nutritional compositions to individuals in need of same are also provided. Methods for modulating the affects of MDSC's are also provided.Type: ApplicationFiled: March 15, 2012Publication date: January 30, 2014Applicant: NESTEC S.A.Inventor: Norman Alan Greenberg
-
Publication number: 20140017291Abstract: The invention relates to porous films comprising crosslinked electrospun hydrogel fibers. Viable microbes are encapsulated within the crosslinked electrospun hydrogel fibers. The crosslinked electrospun hydrogel fibers are water insoluble and permeable. The invention also relates to methods of making and using such porous films.Type: ApplicationFiled: December 21, 2012Publication date: January 16, 2014Inventors: Devicharan Chidambaram, Ying Liu, Miriam H. Rafailovich
-
Patent number: 8628766Abstract: The present invention pertains to the use of Streptococcus suis antigens corresponding to Streptococcus suis bacteria of a predetermined serotype in the manufacture of a vaccine for administration to a sow or gilt, to protect a piglet through the intake of colostrum of the said sow or gilt, against a disorder arising from Streptococcus suis bacteria of a serotype other than the predetermined one. The invention also pertains to Streptococcus suis antigens for use in the manufacture of such a vaccine.Type: GrantFiled: March 25, 2010Date of Patent: January 14, 2014Assignee: Intervet International B.V.Inventors: Henricus Leo Bernardus Maria Klaasen, Ruud Philip Antoon Maria Segers
-
Patent number: 8628763Abstract: The present invention relates to a method for the preparation of a fermented milk product comprising Bifidobacteria in combination with lactic acid bacteria of the species Lactococcus lactis, Sterptococcus thermophilus, and/or Lactobacillus bulgaricus. The problem to be solved is to provide a method to improve growth of Bifidobacteria population in milk during the fermentation process for making fermented milk products (e.g. a yogurt) in order to obtain a high cell count of Bifidobacteria in the final product.Type: GrantFiled: August 28, 2009Date of Patent: January 14, 2014Assignee: CHR-Hansen A/SInventors: Ditte Marie Folkenberg, Cecile Seimandi
-
Publication number: 20130336941Abstract: The present invention relates to methods for a ong-term and sustained release of flavonoids, in particular rhamnose-containing flavonoids, and for prolonging the uptake of said flavonoids in the gastro-intestinal tract. It further relates to compositions comprising said flavonoid and ?-rhamnosidase. It also encompasses compositions comprising hesperidin and hesperetin-7-gluoside.Type: ApplicationFiled: March 15, 2013Publication date: December 19, 2013Inventors: Myriam Richelle, Gary . Williamson, Ivana Jankovic, Maarit Rein
-
Publication number: 20130330307Abstract: A feed additive composition comprising a direct fed microbial in combination with a protease, and a phytase, and a method for improving the performance of a subject or for improving digestibility of a raw material in a feed (e.g. nutrient digestibility, such as amino acid digestibility), or for improving nitrogen retention, or for improving the subject's resistance to necrotic enteritis or for improving feed conversion ratio (FCR) or for improving weight gain in a subject or for improving feed efficiency in a subject or for modulating (e.g. improving) the immune response of the subject or for promoting the growth of beneficial bacteria in the gastrointestinal tract of a subject, which method comprising administering to a subject a direct fed microbial in combination with a protease and a phytase.Type: ApplicationFiled: January 19, 2012Publication date: December 12, 2013Applicant: DUPONT NUTRITION BIOSCIENCES APSInventor: Luis Fernando Romero Millan
-
Publication number: 20130330308Abstract: A feed additive composition comprising a direct fed microbial (DFM) in combination with a phytase derivable from Citrobacter spp. and a method for improving the performance of a subject or for improving digestibility of a raw material in a feed (e.g. nutrient digestibility, such as amino acid digestibility), or for improving nitrogen retention, or for avoiding the negative effects of necrotic enteritis or for improving feed conversion ratio (FCR) or for improving weight gain in a subject or for improving feed efficiency in a subject or for modulating (e.g. improving) the immune response of the subject, or for promoting the growth of beneficial bacteria in the gastrointestinal tract of a subject or for reducing populations of pathogenic bacteria in the gastrointestinal tract of a subject, or for reducing nutrient excretion in manure, which method comprising administering to a subject a direct fed microbial (DFM) in combination with a phytase derivable from Citrobacter spp.Type: ApplicationFiled: January 19, 2012Publication date: December 12, 2013Applicant: DUPONT NUTRITION BIOSCIENCES APSInventors: Luis Fernando Romero Millan, Luke Bernard, Peter Plumstead
-
Patent number: 8597638Abstract: The invention relates to a zinc-enriched biomass comprising living or subsequently killed micro-organisms, selected from the group consisting of Streptococcus thermophilus and Bifidobacterium animalis subsp. lactis and combinations thereof, a method for the manufacture of said zinc-enriched biomass, as well as food preparations, nutraceutic products, functional foods, cosmetic and cosmeceutic products, and food supplements, comprising the said biomass. Furthermore, new micro-organism strains are described which are able to concentrate zinc within the cell in very high amounts and therefore are particularly suitable for use in the method of the invention.Type: GrantFiled: July 22, 2008Date of Patent: December 3, 2013Assignee: Bioman S.R.L.Inventors: Alberto Benedetti, Francesco Girardo
-
Patent number: 8591882Abstract: An object of the present invention is to find a novel and useful component in a culture supernatant of a lactic acid bacterium and to provide an effective utilization method of the component. The utilization method is a cytoprotective agent containing, as an active ingredient, a low-molecular-weight fraction in a culture supernatant of a lactic acid bacterium belonging to Streptococcus thermophilus.Type: GrantFiled: August 12, 2011Date of Patent: November 26, 2013Assignee: Kabushiki Kaisha Yakult HonshaInventors: Naoki Izawa, Tomoko Kurasawa, Toshiro Sone, Katsuyoshi Chiba
-
Publication number: 20130302296Abstract: An embodiment is a method of preventing, mitigating or treating Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) that includes administering an effective amount of a medicament comprised of Streptococcus oralis 89a to a human to prevent, mitigate or treat PANDAS.Type: ApplicationFiled: May 3, 2013Publication date: November 14, 2013Applicant: NuBiome, Inc.Inventors: Brian C. Lue, Fredrick C. Westall
-
Patent number: 8529887Abstract: The present invention relates generally to the field of nutrition, more particularly to the use of probiotics in nutrition. In particular the present invention relates to the use of a probiotic or of a mixture of probiotics in the manufacture of a nutritional composition or a medicament to act the colon in a pre- or post surgical environment.Type: GrantFiled: May 14, 2008Date of Patent: September 10, 2013Assignee: Nestec S.A.Inventor: Eduardo Schiffrin
-
Publication number: 20130224167Abstract: The present invention relates to non-replicating probiotic micro-organisms and their health benefits. In particular, the present invention provides a means to help parents to protect their children from infections. The subject matter of the present inventions allows it to reduce absence from school or daycare. One embodiment of the present invention relates to a composition comprising non-replicating probiotic micro-organisms for use in the prevention or treatment of infections in children to reduce absence from school or daycare.Type: ApplicationFiled: November 9, 2011Publication date: August 29, 2013Applicant: NESTEC S.A.Inventors: Valerie Petit, Clara Lucia Garcia-Rodenas, Monique Julita, Annick Mercenier, Guenolee Prioult, Sophie Nutten
-
Publication number: 20130224165Abstract: The present invention relates to the field of drinkable yoghurt compositions. In particular, the present invention provides drinkable yoghurt compositions comprising non-replicating probiotic micro-organisms. These non-replicating probiotic micro-organisms may be bioactive heat treated probiotic micro-organisms, for example. The present invention also relates to health benefits provided by these non-replicating probiotic micro-organisms.Type: ApplicationFiled: November 7, 2011Publication date: August 29, 2013Applicant: Single Buoy Moorings, IncInventors: Annick Mercenier, Guenolee Prioult, Sophie Nutten
-
Publication number: 20130224166Abstract: The present invention relates to the field of powdered cereal compositions to be reconstituted in milk, infant formula or water. In particular, the present invention relates to powdered cereal compositions to be administered to infants or young children. The powdered cereal compositions may be used to strengthen the immune system and/or to treat or prevent inflammatory disorders. For example these benefits can be provided by probiotic micro-organisms. An embodiment of the present invention relates to a powdered cereal composition comprising non-replicating probiotic-micro-organisms, for example bioactive heat treated probiotic micro-organisms.Type: ApplicationFiled: November 2, 2011Publication date: August 29, 2013Applicant: NESTEC S.A.Inventors: Annick Mercenier, Guenolee Prioult, Sophie Nutten
-
Publication number: 20130209404Abstract: The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effector. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease.Type: ApplicationFiled: March 14, 2013Publication date: August 15, 2013Applicant: NORDISK REBALANCE A/SInventor: Nordisk Rebalance A/S
-
Publication number: 20130209429Abstract: The current invention provides use of a CLA-producing bacterium for the in vivo conversion in the gut of polyunsaturated fatty acids to CLA. The CLA-producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria.Type: ApplicationFiled: March 27, 2013Publication date: August 15, 2013Applicants: University College Cork, National University of Ireland, Cork, Alimentary Health Ltd., TEAGASC - The Agriculture and Food Development AuthorityInventors: University College Cork, National University of Ireland, Cork, TEAGASC - The Agriculture and Food Development Authority, Alimentary Health Ltd.
-
Publication number: 20130195821Abstract: The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effector. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease.Type: ApplicationFiled: March 14, 2013Publication date: August 1, 2013Applicant: NORDISK REBALANCE A/SInventor: NORDISK REBALANCE A/S
-
Patent number: 8481025Abstract: The present invention provides a composition comprising prebiotic and probiotic components and is used to reduce elevated levels of nitrogenous waste products and to promote a healthy bowel microenvironment.Type: GrantFiled: September 4, 2012Date of Patent: July 9, 2013Assignee: Kibow Biotech, Inc.Inventor: Natarajan Ranganathan
-
Publication number: 20130129653Abstract: The present invention is directed toward protecting the cosmetic use of at least an effective amount of a lysate of at least one microorganism of the genus Bifidobacterium species, or a fraction thereof, for preventing and/or treating body odor.Type: ApplicationFiled: April 22, 2011Publication date: May 23, 2013Applicant: L'OREALInventors: Isabelle Castiel, Audrey Gueniche, Dominique Bernard
-
Publication number: 20130121976Abstract: The present invention discloses strains of Lactobacillus and Streptococcus which have a capacity to degrade gliadin peptides involved in coeliac disease and which peptide degrading activity is stable under low pH and in the presence of mammalian digestive enzymes. These strains are suitable in a product for use in prevention and/or treatment of celiac disease.Type: ApplicationFiled: March 12, 2010Publication date: May 16, 2013Inventors: Agusti Montserrat Carreras, Montserrat Andreu Corominas, Daniel Ramon Vidal, Salvador Genoves Martinez, Esther Bataller Leiva
-
Publication number: 20130095086Abstract: An isolated Lactobacillus paracasei strain GMNL-133 is disclosed, which was deposited in the China Center for Type Culture Collection (CCTCC) under the accession number of CCTCC M 2011331 is disclosed. The isolated Lactobacillus paracasei strain GMNL-133 is used for preparing a composition for use in the treatment of atopic dermatitis or other allergic diseases in an effective amount. And a composition for use in the treatment of atopic dermatitis or other allergic diseases comprises an effective amount of the Lactobacillus paracasei strain GMNL-133 is also disclosed.Type: ApplicationFiled: October 14, 2011Publication date: April 18, 2013Applicant: GENMONT BIOTECH INCORPORATIONInventors: Ying-Chen LU, Feng-Ching HSIEH
-
Publication number: 20130095044Abstract: A new microbial strain of the species Streptococcus salivarius for use in the treatment of inflammatory processes with or without infectious etiology. A further object of the present invention compositions including the strain and uses thereof.Type: ApplicationFiled: October 4, 2012Publication date: April 18, 2013Applicant: D.M.G. ITALIA SrlInventor: D.M.G. ITALIA Srl
-
Publication number: 20130089530Abstract: The invention relates to compositions for treating parasitic worm infections in a mammal. The composition includes an amount of intracellular components of lysed, beneficial, soil-inhabiting yeast cells sufficient to treat parasitic worm infections in a mammal; and/or an amount of whole or lysed soil-inhabiting bacteria cells, wherein the amount is sufficient to treat parasitic worm infections in a mammal, and optionally a pharmaceutically suitable carrier.Type: ApplicationFiled: October 11, 2012Publication date: April 11, 2013Applicant: MICROBES, INC.Inventor: MICROBES, INC.
-
Publication number: 20130084271Abstract: A probiotic composition, delivery device, method of forming, and a method for delivery are disclosed. The composition may be in the form of a spray, mist, film, or the like suitable for use with any pre-formulated pet food product, whether in solid or liquid form, and further to the use of the spray directly on the coat or skin of an animal. The probiotic spray may also be applied directly into a cavity of the animal, for example into its mouth or nasal passages. The probiotic composition provides multiple strains or species of viable bacteria that provide health benefits when ingested, and is shown herein primarily for consumption by or use on/in animals, though the invention is not limited in any way to use strictly for animal intake, but may also be suitably used for human ingestion.Type: ApplicationFiled: October 3, 2012Publication date: April 4, 2013Applicant: Kelly Foods CorporationInventor: Kelly Foods Corporation